Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
BioCryst Pharmaceuticals Inc banner

BioCryst Pharmaceuticals Inc
NASDAQ:BCRX

Watchlist Manager
BioCryst Pharmaceuticals Inc Logo
BioCryst Pharmaceuticals Inc
NASDAQ:BCRX
Watchlist
Price: 7.445 USD -0.47% Market Closed
Market Cap: $1.8B
Write Note Create Alert Ask AI
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

BCRX Price Targets Summary
BioCryst Pharmaceuticals Inc

Wall Street analysts forecast BCRX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BCRX is 22.213 USD with a low forecast of 14.14 USD and a high forecast of 33.6 USD.

BCRX Lowest Forecast
Wall Street Target
14.14 USD
90% Upside
BCRX Average Forecast
Wall Street Target
22.213 USD
198% Upside
BCRX Highest Forecast
Wall Street Target
33.6 USD
351% Upside
Lowest
Price Target
14.14 USD
90% Upside
Average
Price Target
22.213 USD
198% Upside
Highest
Price Target
33.6 USD
351% Upside
BioCryst Pharmaceuticals Inc Competitors:
Price Targets
RCKT
Rocket Pharmaceuticals Inc
104% Upside
PRQR
ProQR Therapeutics NV
582% Upside
CENT
Central Garden & Pet Co
23% Upside
RCKT
Rocket Pharmaceuticals Inc
104% Upside
PRQR
ProQR Therapeutics NV
582% Upside
CENT
Central Garden & Pet Co
23% Upside

Revenue
Forecast

27% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
27% / Year
Past Growth
19% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 13 years the compound annual growth rate for BioCryst Pharmaceuticals Inc's revenue is 27%. The projected CAGR for the next 4 years is 19%.

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-64%
Average Miss

What are analyst estimates?

See Also

Summary
BCRX intrinsic value, competitors valuation, and company profile.
DCF Valuation
BCRX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BCRX stock valuation using valuation multiples.
Wall Street Estimates
BCRX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BCRX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCRX's stock price target?
Price Target
22.213 USD

According to Wall Street analysts, the average 1-year price target for BCRX is 22.213 USD with a low forecast of 14.14 USD and a high forecast of 33.6 USD.

What is BioCryst Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
19%

For the last 13 years the compound annual growth rate for BioCryst Pharmaceuticals Inc's revenue is 27%. The projected CAGR for the next 4 years is 19%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 319,700+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.